Trial Profile
A cross-sectional study to evaluate the anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7–8 years of age
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs DTaP poliovirus vaccine (Primary)
- Indications Pertussis
- Focus Pharmacodynamics
- 29 Dec 2015 New trial record